XML 62 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Changes to Impacted Consolidated Statements of Operations (Details) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Total Sales $ 2,898,000 $ 3,427,000 $ 3,008,000 $ 2,503,000 $ 3,314,000 $ 3,019,000 $ 2,917,000 $ 3,915,000 $ 4,233,000 $ 2,779,000 $ 3,037,000 $ 1,532,000 $ 11,835,882 $ 13,164,933 $ 11,581,496
Total Cost of Sales                         10,352,756 11,596,443 10,983,538
Gross Profit (126,000) 868,000 262,000 479,000 (12,000) 363,000 359,000 860,000 371,000 16,000 464,000 (252,000) 1,483,126 1,568,490 597,958
Operating Expenses:                              
Research and Development                         12,676,688 11,674,954 7,568,074
Selling and Marketing                         8,078,538 6,118,929 4,039,772
General and Administrative                         21,038,562 22,502,833 6,915,213
Depreciation and Amortization                         1,788,584 988,104 1,128,831
Loss on Fixed Asset Disposal                         35,350 183,614 0
Impairment of Patents and Trademarks                         97,675 80,163 73,532
Total Operating Expenses                         43,715,397 41,548,597 19,725,422
Loss From Operations                         (42,232,271) (39,980,107) (19,127,464)
Total Other Expense, Net                         1,468,698 (397,053) 1,175,292
Net Loss $ (10,759,000) $ (9,477,000) $ (10,022,000) $ (10,506,000) $ (11,493,000) $ (10,488,000) $ (9,245,000) $ (9,151,000) $ (3,590,000) $ (4,761,000) $ (4,239,000) $ (5,362,000) $ (40,763,573) $ (40,377,160) $ (17,952,172)
Basic Loss per Common Share $ (0.17) $ (0.15) $ (0.16) $ (0.16) $ (0.17) $ (0.17) $ (0.15) $ (0.17) $ (0.09) $ (0.13) $ (0.13) $ (0.18) $ (0.64) $ (0.66) $ (0.53)
Diluted Loss per Common Share $ (0.17) $ (0.15) $ (0.16) $ (0.16) $ (0.17) $ (0.17) $ (0.15) $ (0.17) $ (0.09) $ (0.13) $ (0.13) $ (0.18) $ (0.64) $ (0.66) $ (0.53)
As Previously Presented                              
Total Sales                           $ 13,164,933 $ 11,581,496
Total Cost of Sales                           10,714,088 9,653,887
Gross Profit                           2,450,845 1,927,609
Operating Expenses:                              
Research and Development                           11,674,954 7,568,074
Selling and Marketing                           6,118,929 4,039,772
General and Administrative                           22,502,833 6,915,213
Depreciation and Amortization                           1,870,459 2,458,482
Loss on Fixed Asset Disposal                           183,614  
Impairment of Patents and Trademarks                           80,163 73,532
Total Operating Expenses                           42,430,952 21,055,073
Loss From Operations                           (39,980,107) (19,127,464)
Total Other Expense, Net                           (397,053) 1,175,292
Net Loss                           (40,377,160) (17,952,172)
Reclassification                              
Total Cost of Sales                           882,355 1,329,651
Gross Profit                           (882,355) (1,329,651)
Operating Expenses:                              
Depreciation and Amortization                           (882,355) (1,329,651)
Total Operating Expenses                           (882,355) (1,329,651)
Revised                              
Total Sales                           13,164,933 11,581,496
Total Cost of Sales                           11,596,443 10,983,538
Gross Profit                           1,568,490 597,958
Operating Expenses:                              
Research and Development                           11,674,954 7,568,074
Selling and Marketing                           6,118,929 4,039,772
General and Administrative                           22,502,833 6,915,213
Depreciation and Amortization                           988,104 1,128,831
Loss on Fixed Asset Disposal                           183,614  
Impairment of Patents and Trademarks                           80,163 73,532
Total Operating Expenses                           41,548,597 19,725,422
Loss From Operations                           (39,980,107) (19,127,464)
Total Other Expense, Net                           (397,053) 1,175,292
Net Loss                           $ (40,377,160) $ (17,952,172)